Logo image of BMRC

BANK OF MARIN BANCORP/CA (BMRC) Stock Fundamental Analysis

NASDAQ:BMRC - Nasdaq - US0634251021 - Common Stock - Currency: USD

24.705  -0.09 (-0.34%)

After market: 24.705 0 (0%)

Fundamental Rating

4

Taking everything into account, BMRC scores 4 out of 10 in our fundamental rating. BMRC was compared to 405 industry peers in the Banks industry. While BMRC seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, BMRC is valued expensive at the moment. Finally BMRC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BMRC had positive earnings in the past year.
In the past year BMRC had a positive cash flow from operations.
BMRC had positive earnings in 4 of the past 5 years.
BMRC had a positive operating cash flow in 4 of the past 5 years.
BMRC Yearly Net Income VS EBIT VS OCF VS FCFBMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.36%, BMRC is doing worse than 94.74% of the companies in the same industry.
Looking at the Return On Equity, with a value of -3.16%, BMRC is doing worse than 94.49% of the companies in the same industry.
Industry RankSector Rank
ROA -0.36%
ROE -3.16%
ROIC N/A
ROA(3y)0.47%
ROA(5y)0.65%
ROE(3y)4.64%
ROE(5y)5.94%
ROIC(3y)N/A
ROIC(5y)N/A
BMRC Yearly ROA, ROE, ROICBMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BMRC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMRC Yearly Profit, Operating, Gross MarginsBMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

4

2. Health

2.1 Basic Checks

BMRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
BMRC has less shares outstanding than it did 1 year ago.
BMRC has more shares outstanding than it did 5 years ago.
There is no outstanding debt for BMRC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BMRC Yearly Shares OutstandingBMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BMRC Yearly Total Debt VS Total AssetsBMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

BMRC has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
BMRC has a better Debt to FCF ratio (0.01) than 91.23% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that BMRC is not too dependend on debt financing.
BMRC's Debt to Equity ratio of 0.00 is amongst the best of the industry. BMRC outperforms 88.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z N/A
ROIC/WACCN/A
WACC13.17%
BMRC Yearly LT Debt VS Equity VS FCFBMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BMRC Yearly Current Assets VS Current LiabilitesBMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

4

3. Growth

3.1 Past

BMRC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.42%.
Measured over the past years, BMRC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.42% on average per year.
The Revenue for BMRC has decreased by -31.98% in the past year. This is quite bad
The Revenue has been decreasing by -6.90% on average over the past years.
EPS 1Y (TTM)-27.42%
EPS 3Y-29.7%
EPS 5Y-18.42%
EPS Q2Q%850%
Revenue 1Y (TTM)-31.98%
Revenue growth 3Y-13.96%
Revenue growth 5Y-6.9%
Sales Q2Q%3.98%

3.2 Future

BMRC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.66% yearly.
Based on estimates for the next years, BMRC will show a quite strong growth in Revenue. The Revenue will grow by 12.10% on average per year.
EPS Next Y72.34%
EPS Next 2Y45.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.57%
Revenue Next 2Y12.1%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BMRC Yearly Revenue VS EstimatesBMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
BMRC Yearly EPS VS EstimatesBMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.45, the valuation of BMRC can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of BMRC indicates a rather expensive valuation: BMRC more expensive than 84.46% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.62. BMRC is around the same levels.
The Price/Forward Earnings ratio is 15.93, which indicates a correct valuation of BMRC.
71.43% of the companies in the same industry are cheaper than BMRC, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, BMRC is valued a bit cheaper.
Industry RankSector Rank
PE 27.45
Fwd PE 15.93
BMRC Price Earnings VS Forward Price EarningsBMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BMRC indicates a slightly more expensive valuation: BMRC is more expensive than 69.42% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.99
EV/EBITDA N/A
BMRC Per share dataBMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

BMRC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BMRC's earnings are expected to grow with 45.66% in the coming years.
PEG (NY)0.38
PEG (5Y)N/A
EPS Next 2Y45.66%
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

BMRC has a Yearly Dividend Yield of 4.03%, which is a nice return.
Compared to an average industry Dividend Yield of 3.19, BMRC pays a bit more dividend than its industry peers.
BMRC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 4.03%

5.2 History

The dividend of BMRC is nicely growing with an annual growth rate of 9.31%!
BMRC has been paying a dividend for at least 10 years, so it has a reliable track record.
BMRC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.31%
Div Incr Years18
Div Non Decr Years19
BMRC Yearly Dividends per shareBMRC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of BMRC are negative and hence is the payout ratio. BMRC will probably not be able to sustain this dividend level.
The dividend of BMRC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-117.49%
EPS Next 2Y45.66%
EPS Next 3YN/A
BMRC Yearly Income VS Free CF VS DividendBMRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

BANK OF MARIN BANCORP/CA

NASDAQ:BMRC (2/21/2025, 8:03:53 PM)

After market: 24.705 0 (0%)

24.705

-0.09 (-0.34%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-27 2025-01-27/bmo
Earnings (Next)04-28 2025-04-28/bmo
Inst Owners59.2%
Inst Owner Change-97.16%
Ins Owners8.41%
Ins Owner Change1.43%
Market Cap397.50M
Analysts81.67
Price Target29.17 (18.07%)
Short Float %3.74%
Short Ratio10.05
Dividend
Industry RankSector Rank
Dividend Yield 4.03%
Yearly Dividend1
Dividend Growth(5Y)9.31%
DP-117.49%
Div Incr Years18
Div Non Decr Years19
Ex-Date02-06 2025-02-06 (0.25)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-31.42%
Min EPS beat(2)-66.42%
Max EPS beat(2)3.59%
EPS beat(4)1
Avg EPS beat(4)-45.73%
Min EPS beat(4)-87.76%
Max EPS beat(4)3.59%
EPS beat(8)2
Avg EPS beat(8)-28.64%
EPS beat(12)5
Avg EPS beat(12)-18.71%
EPS beat(16)9
Avg EPS beat(16)-1.06%
Revenue beat(2)0
Avg Revenue beat(2)-4.02%
Min Revenue beat(2)-4.52%
Max Revenue beat(2)-3.52%
Revenue beat(4)0
Avg Revenue beat(4)-6.14%
Min Revenue beat(4)-10.46%
Max Revenue beat(4)-3.52%
Revenue beat(8)1
Avg Revenue beat(8)-4.45%
Revenue beat(12)5
Avg Revenue beat(12)-0.54%
Revenue beat(16)8
Avg Revenue beat(16)0.77%
PT rev (1m)3.62%
PT rev (3m)14.4%
EPS NQ rev (1m)0.52%
EPS NQ rev (3m)0.52%
EPS NY rev (1m)2.02%
EPS NY rev (3m)2.14%
Revenue NQ rev (1m)2.38%
Revenue NQ rev (3m)2.38%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)1.25%
Valuation
Industry RankSector Rank
PE 27.45
Fwd PE 15.93
P/S 6
P/FCF 21.99
P/OCF 21.56
P/B 0.91
P/tB 1.1
EV/EBITDA N/A
EPS(TTM)0.9
EY3.64%
EPS(NY)1.55
Fwd EY6.28%
FCF(TTM)1.12
FCFY4.55%
OCF(TTM)1.15
OCFY4.64%
SpS4.12
BVpS27.16
TBVpS22.45
PEG (NY)0.38
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.36%
ROE -3.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 27.26%
ROA(3y)0.47%
ROA(5y)0.65%
ROE(3y)4.64%
ROE(5y)5.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA N/A
Cap/Depr 14.14%
Cap/Sales 0.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC13.17%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.42%
EPS 3Y-29.7%
EPS 5Y-18.42%
EPS Q2Q%850%
EPS Next Y72.34%
EPS Next 2Y45.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.98%
Revenue growth 3Y-13.96%
Revenue growth 5Y-6.9%
Sales Q2Q%3.98%
Revenue Next Year14.57%
Revenue Next 2Y12.1%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-62.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.98%
OCF growth 3YN/A
OCF growth 5YN/A